— Know what they know.
Not Investment Advice

OPGN OTC

OpGen, Inc.
1W: -4.4% 1M: -24.7% 3M: +91.6% YTD: +43.2% 1Y: +896.2% 3Y: +82.5% 5Y: -96.0%
$23.91
Last traded 2026-03-20 — delisted
OTC · Healthcare · Medical - Diagnostics & Research · $242.7M mcap · 2M float · 0.348% daily turnover · Short 30% of daily vol

Income Trends

Revenue
$5M +52.0% ▲
5Y CAGR: +8.2%
Gross Profit
$5M +5792.7% ▲
5Y CAGR: +22.6%
Operating Income
$325K +102.1% ▲
Net Income
$12M +136.7% ▲
EPS (Diluted)
$2.30 +105.5% ▲
EBITDA
$12M +141.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$4M$4M$3M$3M$5M
YoY Growth+20.4%+2.2%-39.5%+31.1%+52.0%
Cost of Revenue$4M$3M$3M$4M$33K
Gross Profit$366K$1M-$817K-$91K$5M
Gross Margin8.7%33.9%-31.3%-2.7%99.4%
R&D Expenses$10M$11M$8M$5M$49K
SG&A Expenses$12M$14M$13M$11M$5M
Operating Expenses$22M$25M$34M$34M$5M
Operating Income-$21M-$23M-$22M-$16M$325K
Operating Margin-510.1%-540.5%-852.3%-459.0%6.2%
Interest Expense$3M$5M$3M$2M$8K
Income Before Tax-$26M-$35M-$37M-$33M$12M
Tax Expense$132K$44K$0$0$177K
Net Income-$26M-$35M-$37M-$33M$12M
Net Margin-622.0%-808.3%-1430.1%-955.8%230.8%
EPS (Diluted)$-331.77$-228.00$-152.70$-41.47$2.30
EBITDA-$20M-$27M-$32M-$30M$12M
Shares Outstanding790031833702441587878325M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms